Sumit Mehra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sumit Mehra has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Subash Shanthakumar Heraganahally
Department of Respiratory and Sleep Medicine, Royal Darwin Hospital, Darwin, Australia
7 shared publications Subash Heraganahally
Royal Darwin Hospital, Darwin, Australia
4 shared publicationsDimitar Sajkov
Flinders Medical Centre, Adelaide, SA, Australia
3 shared publications- Henrik Falhammar
Department of Endocrinology, Karolinska University Hospital , Stockholm 171 76
3 shared publications Anuk Kruavit
Respiratory and Sleep Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia
2 shared publicationsSharon Morton
Flinders Medical Centre, Adelaide, SA, Australia
2 shared publications
Latest Publications
- 22 December 2020
- Published by Wiley in Internal Medicine Journal
- Vol. 50 (12) , 1505-1513
2004 chronic obstructive pulmonary disease with and without bronchiectasis in Aboriginal Australians: a comparative study
Background: Chronic respiratory disorders are highly prevalent in Aboriginal Australian population, including chronic obstructive pulmonary disease (COPD) and bronchiectasis. However, there is paucity of information in the literature among Aboriginal patients with underlying COPD with and without bronchiectasis.Aims: In this retrospective study we evaluated the demographic and clinical characteristics of adult Aboriginal Australian patients with a clinical diagnosis of COPD with and without bronchiectasis from the remote communities of the Northern Territory of Australia.Methods: Clinical records were reviewed to extract information on demographics, respiratory and medical comorbid conditions, COPD directed treatment, hospital admission frequency and exacerbations. Chest radiology were reviewed to evaluate the presence or absence of bronchiectasis. Spirometry results, sputum culture and cardiac investigations were also recorded.Results: Of the 767 patients assessed in the remote community respiratory outreach clinics 380 (49%) patients had a clinical diagnosis of COPD. Chest X‐ray and computed tomography scan were available to evaluate the presence of bronchiectasis in 258 patients. Of the 258/380 patients, 176/258 (68.2%) were diagnosed to have COPD alone and 82/258 (31.8%) had bronchiectasis along with COPD. The mean age was 56 and 59 years among patients with and without bronchiectasis, respectively, and 57% were males with bronchiectasis. Patients with bronchiectasis had lower body mass index (22 vs 24 kg/m2), frequent hospital admissions (2.0 vs 1.5/year) and productive cough (32.1% vs 28.9%). Spirometry showed 77% had forced expiratory volume in 1 s (FEV1)/forced vital capacity ratio 1/forced vital capacity ratio was 1 was 39% and 43% respectively.Conclusions: About 32% of Aboriginal Australians had co‐existent bronchiectasis with COPD. Lower body mass index, productive cough, frequent hospital admission and marginally more severe reduction in lung function were noted among patients with COPD and bronchiectasis compared to those with COPD in isolation.
- 22 December 2020
- Published by Wiley in Internal Medicine Journal
- Vol. 50 (12) , 1505-1513
2004 chronic obstructive pulmonary disease with and without bronchiectasis in Aboriginal Australians: a comparative study
Background: Chronic respiratory disorders are highly prevalent in Aboriginal Australian population, including chronic obstructive pulmonary disease (COPD) and bronchiectasis. However, there is paucity of information in the literature among Aboriginal patients with underlying COPD with and without bronchiectasis.Aims: In this retrospective study we evaluated the demographic and clinical characteristics of adult Aboriginal Australian patients with a clinical diagnosis of COPD with and without bronchiectasis from the remote communities of the Northern Territory of Australia.Methods: Clinical records were reviewed to extract information on demographics, respiratory and medical comorbid conditions, COPD directed treatment, hospital admission frequency and exacerbations. Chest radiology were reviewed to evaluate the presence or absence of bronchiectasis. Spirometry results, sputum culture and cardiac investigations were also recorded.Results: Of the 767 patients assessed in the remote community respiratory outreach clinics 380 (49%) patients had a clinical diagnosis of COPD. Chest X‐ray and computed tomography scan were available to evaluate the presence of bronchiectasis in 258 patients. Of the 258/380 patients, 176/258 (68.2%) were diagnosed to have COPD alone and 82/258 (31.8%) had bronchiectasis along with COPD. The mean age was 56 and 59 years among patients with and without bronchiectasis, respectively, and 57% were males with bronchiectasis. Patients with bronchiectasis had lower body mass index (22 vs 24 kg/m2), frequent hospital admissions (2.0 vs 1.5/year) and productive cough (32.1% vs 28.9%). Spirometry showed 77% had forced expiratory volume in 1 s (FEV1)/forced vital capacity ratio 1/forced vital capacity ratio was 1 was 39% and 43% respectively.Conclusions: About 32% of Aboriginal Australians had co‐existent bronchiectasis with COPD. Lower body mass index, productive cough, frequent hospital admission and marginally more severe reduction in lung function were noted among patients with COPD and bronchiectasis compared to those with COPD in isolation.
- 7 September 2020
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (suppl 64)
Adult Bronchiectasis in the Northern Territory of Australia: The Aboriginal and Non-aboriginal comparative study
Background and Aim: Bronchiectasis is a heterogenous disease. The Aboriginal population appear to have a high burden but there is an unmet need to understand the nature of bronchiectasis in the population in comparison to the non-aboriginal counterparts. The aim of the study was to compare the demographic and clinical characteristics of adult Aboriginal and non-Aboriginal patients with clinical diagnosis of bronchiectasis living in the Top End Northern Territory of Australia. Method: A retrospective study conducted in the Top End Northern Territory of Australia. Clinical records were reviewed to extract information on demographics, co-existence of other respiratory and medical co-morbid conditions, and respiratory disease specific investigations and treatment. Results and Conclusions: There were 388 patients diagnosed to have bronchiectasis, of them 258 (66.5%) were Aboriginal Australians. Aboriginal patients were on an average 11 years younger, have higher rates of self-reported alcohol consumption(p<0.001) and smoking, higher co-occurrence with COPD(p<0.001), chronic kidney disease (p<0.001), diabetes(p<0.001), ischemic heart disease(p=0.013), rheumatic heart disease(p=0.006) in comparison to non-Aboriginal patients, in whom GORD (p=0.004) and H/O Non-tubercular Mycobacteria (p=0.013) were more common. FEV1 and FVC values are significantly lower among Aboriginal cohort. The sputum results showed Haemophilus(p<0.001), Moraxella(p=0.001) and Streptococcus(p<0.001) were common organisms in Aboriginal while Aspergillus(p<0.001) and Pseudomonas(p=0.01) were less common in comparison to non-Aboriginals.
- 7 September 2020
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (suppl 64)
Adult Bronchiectasis in the Northern Territory of Australia: The Aboriginal and Non-aboriginal comparative study
Background and Aim: Bronchiectasis is a heterogenous disease. The Aboriginal population appear to have a high burden but there is an unmet need to understand the nature of bronchiectasis in the population in comparison to the non-aboriginal counterparts. The aim of the study was to compare the demographic and clinical characteristics of adult Aboriginal and non-Aboriginal patients with clinical diagnosis of bronchiectasis living in the Top End Northern Territory of Australia. Method: A retrospective study conducted in the Top End Northern Territory of Australia. Clinical records were reviewed to extract information on demographics, co-existence of other respiratory and medical co-morbid conditions, and respiratory disease specific investigations and treatment. Results and Conclusions: There were 388 patients diagnosed to have bronchiectasis, of them 258 (66.5%) were Aboriginal Australians. Aboriginal patients were on an average 11 years younger, have higher rates of self-reported alcohol consumption(p<0.001) and smoking, higher co-occurrence with COPD(p<0.001), chronic kidney disease (p<0.001), diabetes(p<0.001), ischemic heart disease(p=0.013), rheumatic heart disease(p=0.006) in comparison to non-Aboriginal patients, in whom GORD (p=0.004) and H/O Non-tubercular Mycobacteria (p=0.013) were more common. FEV1 and FVC values are significantly lower among Aboriginal cohort. The sputum results showed Haemophilus(p<0.001), Moraxella(p=0.001) and Streptococcus(p<0.001) were common organisms in Aboriginal while Aspergillus(p<0.001) and Pseudomonas(p=0.01) were less common in comparison to non-Aboriginals.
- Open Access
- 1 August 2020
- Published by Taylor & Francis in Nature and Science of Sleep
- Vol. ume 12, 593-602
Gender Differences in the Clinical and Polysomnographic Characteristics Among Australian Aboriginal Patients with Obstructive Sleep Apnea
Background: In this study, we assessed the clinical and polysomnographic (PSG) characteristics according to gender among Australian Aboriginal men and woman diagnosed to have obstructive sleep apnea (OSA). Methods: In this retrospective study, all adult Aboriginal patients over 18 years of age diagnosed to have OSA with an apnea hypopnea index (AHI) > 5/hour over a 5 year period were included. Results: Of the 337 patients (168 females and 169 males), who underwent a diagnostic PSG, 297 (88%) were diagnosed to have OSA (AHI) > 5/hour), 154/297 males (52%) and 143/297 females (48%). Amongst male and female patients with OSA, 63% and 37% were in the severe spectrum (AHI> 30/hour). The male cohort had higher stage N1 NREM sleep (P< 0.001), reduced N3 NREM sleep (P< 0.001), higher AHI severity (P< 0.001), higher NREM AHI (P< 0.001), and high arousal index (P< 0.005). REM sleep-related AHI was higher among female patients with all severity of OSA, along with severe oxygen desaturation during REM sleep. Among patients with severe OSA, the female cohort were younger (age 46 years vs 49 years, P=0.030) and had higher BMI with all severity of OSA, while males had larger neck circumference compared to females. Hypertension increased the odds of severe OSA versus the combined odds of mild and moderate OSA for both genders. Conclusion: This study highlights some important differences in the way sleep apnea manifests in Australian Aboriginal males and females and further studies are warranted to explore avenues to look for a physiological basis for these observations and targeted interventions.
- 1 August 2020
- Published by Taylor & Francis in Nature and Science of Sleep
- Vol. ume 12, 593-602
Open AccessGender Differences in the Clinical and Polysomnographic Characteristics Among Australian Aboriginal Patients with Obstructive Sleep Apnea
Background: In this study, we assessed the clinical and polysomnographic (PSG) characteristics according to gender among Australian Aboriginal men and woman diagnosed to have obstructive sleep apnea (OSA). Methods: In this retrospective study, all adult Aboriginal patients over 18 years of age diagnosed to have OSA with an apnea hypopnea index (AHI) > 5/hour over a 5 year period were included. Results: Of the 337 patients (168 females and 169 males), who underwent a diagnostic PSG, 297 (88%) were diagnosed to have OSA (AHI) > 5/hour), 154/297 males (52%) and 143/297 females (48%). Amongst male and female patients with OSA, 63% and 37% were in the severe spectrum (AHI> 30/hour). The male cohort had higher stage N1 NREM sleep (P< 0.001), reduced N3 NREM sleep (P< 0.001), higher AHI severity (P< 0.001), higher NREM AHI (P< 0.001), and high arousal index (P< 0.005). REM sleep-related AHI was higher among female patients with all severity of OSA, along with severe oxygen desaturation during REM sleep. Among patients with severe OSA, the female cohort were younger (age 46 years vs 49 years, P=0.030) and had higher BMI with all severity of OSA, while males had larger neck circumference compared to females. Hypertension increased the odds of severe OSA versus the combined odds of mild and moderate OSA for both genders. Conclusion: This study highlights some important differences in the way sleep apnea manifests in Australian Aboriginal males and females and further studies are warranted to explore avenues to look for a physiological basis for these observations and targeted interventions.
- Open Access
- 1 January 2020
- Published by Medknow in Lung India
- Vol. 37 (3) , 198-203
The effectiveness of small-bore intercostal catheters versus large-bore chest tubes in the management of pleural disease with the systematic review of literature
The purpose of this study was to compare the effectiveness of small-bore intercostal catheters (SB ICCs; 10-14 Fr) to large-bore intercostal tubes (LB ICTs; >20 Fr) in the management of pleural diseases. A total of 52 patients (42 males) with a mean age of 55 ± 23 years undergoing pleural intervention were included in the analysis. Twenty-five patients (48.1%) had pneumothorax and rest (51.9%) had pleural effusion. Half of the patients underwent SB ICC (mean age: 63 ± 20 years) and the remaining 26 underwent LB ICT (mean age: 47 ± 25 years). SB ICCs were predominantly used in patients with primary pleural effusion and LB ICTs in patients presenting with pneumothorax. Failures were in <20% of SB ICC patients (mainly from loculation) and in <30% with LB ICT patients (from persistent airleak) - difference that was not statistically significant. In both groups, no deaths or major complications directly related to the procedure were observed. However, the proportion that needed surgery was significantly different in two cohorts (18.5% OF SB ICC and 42.3% of LB ICT cohorts). The ICC dwell time was less in SB ICC (5 ± 4 days), compared to LB ICT (8 ± 6 days). SB ICCs were associated with less pain and seem to be tolerated better by the patients. In well-supervised tertiary hospital setting, SB ICCs are as effective as LB ICTs with better patient tolerance, reduced dwell time, and reduced likelihood for surgical intervention.
- 1 January 2020
- Published by Medknow in Lung India
- Vol. 37 (3) , 198-203
Open AccessThe effectiveness of small-bore intercostal catheters versus large-bore chest tubes in the management of pleural disease with the systematic review of literature
The purpose of this study was to compare the effectiveness of small-bore intercostal catheters (SB ICCs; 10-14 Fr) to large-bore intercostal tubes (LB ICTs; >20 Fr) in the management of pleural diseases. A total of 52 patients (42 males) with a mean age of 55 ± 23 years undergoing pleural intervention were included in the analysis. Twenty-five patients (48.1%) had pneumothorax and rest (51.9%) had pleural effusion. Half of the patients underwent SB ICC (mean age: 63 ± 20 years) and the remaining 26 underwent LB ICT (mean age: 47 ± 25 years). SB ICCs were predominantly used in patients with primary pleural effusion and LB ICTs in patients presenting with pneumothorax. Failures were in <20% of SB ICC patients (mainly from loculation) and in <30% with LB ICT patients (from persistent airleak) - difference that was not statistically significant. In both groups, no deaths or major complications directly related to the procedure were observed. However, the proportion that needed surgery was significantly different in two cohorts (18.5% OF SB ICC and 42.3% of LB ICT cohorts). The ICC dwell time was less in SB ICC (5 ± 4 days), compared to LB ICT (8 ± 6 days). SB ICCs were associated with less pain and seem to be tolerated better by the patients. In well-supervised tertiary hospital setting, SB ICCs are as effective as LB ICTs with better patient tolerance, reduced dwell time, and reduced likelihood for surgical intervention.
- 14 October 2019
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 43 (3)
Sleep apnoea among Australian Aboriginal and non-Aboriginal patients in the Northern Territory of Australia—a comparative study
Australian Aboriginal and Torres Straight Islanders (ATSI) are noted to have a higher burden of chronic health conditions. However, there is a paucity of data on Obstructive Sleep Apnoea (OSA) in this population. In this retrospective study, we evaluated the clinical and polysomnographic (PSG) characteristics of ATSI and non- ATSI adult patients who underwent diagnostic PSG between 2011 and 2015. There were a total of 3078 patients. Of the total, 403 (13%) were of ATSI origin. Amongst those of ATSI origin, 61% were male and 39% females, while amongst the non-ATSI cohort, 66% were males. The median age was 47.8 years in ATSI and 51.5 years in the non- ATSI cohort. In the combined cohort, body mass index was >30 kg/m2 ( 61%), hypertension (14.4%), diabetes ( 17.8%) and heart disease ( 23.3%). The ATSI patients had higher rates of class III obesity (27 v 15%), hypertension (26 v 14%), cardiac disease (34 v 23%) and diabetes (37 v 17%). Among all the study participants, the PSG confirmed 83.7% of the patients had an apnoea-hypopnea index (AHI) more than 5/hour, mild (AHI 5-15/hour) in (28.4%), moderate (AHI 15-30/hour) in (22.3%), and severe (AHI > 30/hour) in (33.0%). Among the ATSI patients, 46% had severe OSA. The median total AHI value was higher in the ATSI population (25, IQR: 11 – 58) compared to the non-ATSI (17, IQR: 7 – 36), and in rural/remote population (19, IQR: 8 – 42) compared to urban (17, IQR: 7 – 37). This trend was similar for NREM (Non Rapid Eye Movement)-AHI and REM (Rapid Eye Movement) AHI scores, although statistically significant difference was found only with ATSI status. In the combined cohort the probability of (OR= 1.62, 95% CI: 1.32-2.00, p<0.001) of severe OSA was 62% higher in individual with hypertension , however, when stratified by ATSI status, the association was only significant in the non-ATSI population (OR=1.53 95% CI: 1.21 – 1.94, p<0.001). The odds of severe AHI was also significantly associated with heart disease (1.37; 95%CI: 1.14,1.63, p<0.001), diabetes (1.74; 95%CI: 1.43,2.10; p<0.001) and smoking (1.28; 95%CI: 1.09,1.50, p=0.0023) in the overall study cohort. In both ATSI and non- ATSI patients, BMI, neck circumference, sleep efficiency, wake after sleep onset and respiratory arousal index were significantly higher and independently associated with severe AHI.
- 14 October 2019
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 43 (3)
Sleep apnoea among Australian Aboriginal and non-Aboriginal patients in the Northern Territory of Australia—a comparative study
Australian Aboriginal and Torres Straight Islanders (ATSI) are noted to have a higher burden of chronic health conditions. However, there is a paucity of data on Obstructive Sleep Apnoea (OSA) in this population. In this retrospective study, we evaluated the clinical and polysomnographic (PSG) characteristics of ATSI and non- ATSI adult patients who underwent diagnostic PSG between 2011 and 2015. There were a total of 3078 patients. Of the total, 403 (13%) were of ATSI origin. Amongst those of ATSI origin, 61% were male and 39% females, while amongst the non-ATSI cohort, 66% were males. The median age was 47.8 years in ATSI and 51.5 years in the non- ATSI cohort. In the combined cohort, body mass index was >30 kg/m2 ( 61%), hypertension (14.4%), diabetes ( 17.8%) and heart disease ( 23.3%). The ATSI patients had higher rates of class III obesity (27 v 15%), hypertension (26 v 14%), cardiac disease (34 v 23%) and diabetes (37 v 17%). Among all the study participants, the PSG confirmed 83.7% of the patients had an apnoea-hypopnea index (AHI) more than 5/hour, mild (AHI 5-15/hour) in (28.4%), moderate (AHI 15-30/hour) in (22.3%), and severe (AHI > 30/hour) in (33.0%). Among the ATSI patients, 46% had severe OSA. The median total AHI value was higher in the ATSI population (25, IQR: 11 – 58) compared to the non-ATSI (17, IQR: 7 – 36), and in rural/remote population (19, IQR: 8 – 42) compared to urban (17, IQR: 7 – 37). This trend was similar for NREM (Non Rapid Eye Movement)-AHI and REM (Rapid Eye Movement) AHI scores, although statistically significant difference was found only with ATSI status. In the combined cohort the probability of (OR= 1.62, 95% CI: 1.32-2.00, p<0.001) of severe OSA was 62% higher in individual with hypertension , however, when stratified by ATSI status, the association was only significant in the non-ATSI population (OR=1.53 95% CI: 1.21 – 1.94, p<0.001). The odds of severe AHI was also significantly associated with heart disease (1.37; 95%CI: 1.14,1.63, p<0.001), diabetes (1.74; 95%CI: 1.43,2.10; p<0.001) and smoking (1.28; 95%CI: 1.09,1.50, p=0.0023) in the overall study cohort. In both ATSI and non- ATSI patients, BMI, neck circumference, sleep efficiency, wake after sleep onset and respiratory arousal index were significantly higher and independently associated with severe AHI.
- Open Access
- 1 September 2019
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 14, 2205-2217
Chronic Obstructive Pulmonary Disease In Aboriginal Patients Of The Northern Territory Of Australia: A Landscape Perspective
Background: The Aboriginal population of Australia has a higher burden of chronic health conditions than non-Aboriginal Australians. However, there is a paucity of data on clinical and demographic characteristics of chronic obstructive pulmonary disease (COPD) in this population. Method: In this retrospective study we evaluated the clinical, demographic and environmental influences in adult Aboriginal patients with COPD living in the regional and remote communities of the Northern Territory of Australia. Results: There were 380 patients (49%) with a diagnosis of COPD of the 767 patients referred to specialist respiratory outreach clinics. The mean age was 57 years (56% were female) and mean±SD BMI was 24.30±7.01 kg/m2. Smoking history was noted in 93% of the study cohort. The most common respiratory symptom was shortness of breath in 62%, and inhaled medications (salbutamol, tiotropium, salmeterol/fluticasone) were used by 79%, 44% and 58% of patients, respectively. Spirometry showed obstructive impairment (FEV1/FVC 1 42% of predicted, and a bronchodilator response was present in 28.6%. Comorbid bronchiectasis was diagnosed in 49.8% along with COPD. The relationship between COPD and community demography showed a higher proportion of smokers and those with underlying bronchiectasis to have lower FEV1/FVC ratios. Communities with a higher proportion of asthma were younger and had higher smoking rates. Mortality increased with increasing number of exacerbations and hospital admissions. Conclusion: The Aboriginal population with COPD has a higher prevalence of smoking, moderate to severe airflow obstruction on spirometry and frequently co-diagnosed bronchiectasis with increased severity of ventilatory impairment.
- 1 September 2019
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 14, 2205-2217
Open AccessChronic Obstructive Pulmonary Disease In Aboriginal Patients Of The Northern Territory Of Australia: A Landscape Perspective
Background: The Aboriginal population of Australia has a higher burden of chronic health conditions than non-Aboriginal Australians. However, there is a paucity of data on clinical and demographic characteristics of chronic obstructive pulmonary disease (COPD) in this population. Method: In this retrospective study we evaluated the clinical, demographic and environmental influences in adult Aboriginal patients with COPD living in the regional and remote communities of the Northern Territory of Australia. Results: There were 380 patients (49%) with a diagnosis of COPD of the 767 patients referred to specialist respiratory outreach clinics. The mean age was 57 years (56% were female) and mean±SD BMI was 24.30±7.01 kg/m2. Smoking history was noted in 93% of the study cohort. The most common respiratory symptom was shortness of breath in 62%, and inhaled medications (salbutamol, tiotropium, salmeterol/fluticasone) were used by 79%, 44% and 58% of patients, respectively. Spirometry showed obstructive impairment (FEV1/FVC 1 42% of predicted, and a bronchodilator response was present in 28.6%. Comorbid bronchiectasis was diagnosed in 49.8% along with COPD. The relationship between COPD and community demography showed a higher proportion of smokers and those with underlying bronchiectasis to have lower FEV1/FVC ratios. Communities with a higher proportion of asthma were younger and had higher smoking rates. Mortality increased with increasing number of exacerbations and hospital admissions. Conclusion: The Aboriginal population with COPD has a higher prevalence of smoking, moderate to severe airflow obstruction on spirometry and frequently co-diagnosed bronchiectasis with increased severity of ventilatory impairment.
- 16 April 2019
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 95 (1123) , 245-250
New cost-effective pleural procedure training: manikin-based model to increase the confidence and competency in trainee medical officers
Purpose of the study Pleural diseases are common in clinical practice. Doctors in training often encounter these patients and are expected to perform diagnostic and therapeutic pleural procedures with confidence and safely. However, pleural procedures can be associated with significant complications, especially when performed by less experienced. Structured training such as use of training manikin and procedural skills workshop may help trainee doctors to achieve competence. However, high costs involved in acquiring simulation technology or attending a workshop may be a hurdle. We hereby describe a training model using a simple manikin developed in our institution and provide an effective way to document skill acquisition and assessment among trainee medical officers. Study design This was a prospective observational study. The need for training, competence and confidence of trainees in performing pleural procedures was assessed through an online survey. Trainees underwent structured simulation training through a simple manikin developed at our institute. Follow-up survey after the training was then performed to access confidence and competence in performing pleural procedures. Results Forty-seven trainees responded to an online survey and 91% of those expressed that they would like further training in pleural procedure skills. 81% and 85% of responders, respectively, indicated preferred method of training is either practising on manikin or performing the procedure under supervision. Follow-up survey showed improvement in the confidence and competence. Conclusion Our pleural procedure training manikin model is a reliable, novel and cost-effective method for acquiring competences in pleural procedures.
- 16 April 2019
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 95 (1123) , 245-250
New cost-effective pleural procedure training: manikin-based model to increase the confidence and competency in trainee medical officers
Purpose of the study Pleural diseases are common in clinical practice. Doctors in training often encounter these patients and are expected to perform diagnostic and therapeutic pleural procedures with confidence and safely. However, pleural procedures can be associated with significant complications, especially when performed by less experienced. Structured training such as use of training manikin and procedural skills workshop may help trainee doctors to achieve competence. However, high costs involved in acquiring simulation technology or attending a workshop may be a hurdle. We hereby describe a training model using a simple manikin developed in our institution and provide an effective way to document skill acquisition and assessment among trainee medical officers. Study design This was a prospective observational study. The need for training, competence and confidence of trainees in performing pleural procedures was assessed through an online survey. Trainees underwent structured simulation training through a simple manikin developed at our institute. Follow-up survey after the training was then performed to access confidence and competence in performing pleural procedures. Results Forty-seven trainees responded to an online survey and 91% of those expressed that they would like further training in pleural procedure skills. 81% and 85% of responders, respectively, indicated preferred method of training is either practising on manikin or performing the procedure under supervision. Follow-up survey showed improvement in the confidence and competence. Conclusion Our pleural procedure training manikin model is a reliable, novel and cost-effective method for acquiring competences in pleural procedures.
- Open Access
- 1 January 2019
- Published by Elsevier in Respiratory Medicine Case Reports
- Vol. 26, 94-97
Pulmonary AL- amyloidosis masquerading as lung malignancy in an Australian Indigenous patient with Sjogren's syndrome
- 1 January 2019
- Published by Elsevier in Respiratory Medicine Case Reports
- Vol. 26, 94-97
Open AccessPulmonary AL- amyloidosis masquerading as lung malignancy in an Australian Indigenous patient with Sjogren's syndrome
- 21 September 2018
- Published by Wiley in Internal Medicine Journal
- Vol. 49 (2) , 217-224
Prevalence and nature of lung function abnormalities among Indigenous Australians referred to specialist respiratory outreach clinics in the Northern Territory
Background: Poor lung function is a predictor of future all‐cause mortality. In Australia, respiratory diseases are particularly prevalent among the indigenous population, especially in remote communities. However, there are little published pulmonary function tests’ (PFT) data of remote‐based adult indigenous patients.Aim: To evaluate the severity of airflow obstruction and other PFT abnormalities of adults referred to specialist respiratory clinics in remote indigenous communities.Methods: Retrospective analysis of PFT (pre‐ and post‐bronchodilator spirometry, total lung capacity (TLC) and diffusing capacity to carbon monoxide (DLCO)) of indigenous patients collected during specialist respiratory clinics in remote Northern Territory (NT) indigenous communities (Australia) between 2013 and 2015. The National Health and Nutrition Examination Survey (NHANES) III without ethnic correction was used as the reference.Results: Of the 357 patients, 150 had acceptable spirometry, and 71 had acceptable DLCO and TLC studies. Despite the relatively young age (mean = 49 years, SD = 12.9), their lung function was generally low; mean % predicted values were FEV1 = 55% (SD = 20.5%), FVC = 61% (SD = 15.6%), DLCO = 64.0% (SD = 19.7%) and TLC = 70.1% (SD = 18.2%). Mean FEV1/FVC ratio was preserved (0.71, SD = 0.16). Post‐bronchodilator airflow obstruction (FEV1/FVC < 0.7) was observed in 37% of patients, where a large proportion (67%) demonstrated at least a severe airflow obstruction, with a mean FEV1 of 41% predicted.Conclusion: In this first study of PFT findings of indigenous adults from a remote‐based clinical service, we found a high rate of at least moderate airflow limitation and low FVC along with preserved FEV1/FVC ratio. Increased awareness and screening for reduced lung function needs to be considered in this population.
- 21 September 2018
- Published by Wiley in Internal Medicine Journal
- Vol. 49 (2) , 217-224
Prevalence and nature of lung function abnormalities among Indigenous Australians referred to specialist respiratory outreach clinics in the Northern Territory
Background: Poor lung function is a predictor of future all‐cause mortality. In Australia, respiratory diseases are particularly prevalent among the indigenous population, especially in remote communities. However, there are little published pulmonary function tests’ (PFT) data of remote‐based adult indigenous patients.Aim: To evaluate the severity of airflow obstruction and other PFT abnormalities of adults referred to specialist respiratory clinics in remote indigenous communities.Methods: Retrospective analysis of PFT (pre‐ and post‐bronchodilator spirometry, total lung capacity (TLC) and diffusing capacity to carbon monoxide (DLCO)) of indigenous patients collected during specialist respiratory clinics in remote Northern Territory (NT) indigenous communities (Australia) between 2013 and 2015. The National Health and Nutrition Examination Survey (NHANES) III without ethnic correction was used as the reference.Results: Of the 357 patients, 150 had acceptable spirometry, and 71 had acceptable DLCO and TLC studies. Despite the relatively young age (mean = 49 years, SD = 12.9), their lung function was generally low; mean % predicted values were FEV1 = 55% (SD = 20.5%), FVC = 61% (SD = 15.6%), DLCO = 64.0% (SD = 19.7%) and TLC = 70.1% (SD = 18.2%). Mean FEV1/FVC ratio was preserved (0.71, SD = 0.16). Post‐bronchodilator airflow obstruction (FEV1/FVC < 0.7) was observed in 37% of patients, where a large proportion (67%) demonstrated at least a severe airflow obstruction, with a mean FEV1 of 41% predicted.Conclusion: In this first study of PFT findings of indigenous adults from a remote‐based clinical service, we found a high rate of at least moderate airflow limitation and low FVC along with preserved FEV1/FVC ratio. Increased awareness and screening for reduced lung function needs to be considered in this population.